We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lumora Acquired by ERBA Diagnostics Mannheim

News   Sep 16, 2015

 
Lumora Acquired by ERBA Diagnostics Mannheim
 
 
Advertisement
 

RELATED ARTICLES

An Epigenetic Signature for COVID-19 Severity?

News

An article published in the journal EBiomedicine by the group of Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute and Dr. Aurora Pujol, head of the Neurometabolic Diseases Group of the Bellvitge Biomedical Research Institute (IDIBELL), shows that the epigenetic endowment of each person influences the severity of the COVID-19 disease.

READ MORE

Blood Test Detects Marker of Metastatic Cancers, Infection and Neurological Disease

News

Scientists at the Walter Reed Army Institute of Research demonstrated the potential of a novel blood test for cathepsin B, a well-studied protein important to brain development and function, as an indicator for a range of disease states.

READ MORE

What Spit Samples Can Tell Us About Pediatric OCD

News

Researchers at the University of Calgary and The Hospital for Sick Children (SickKids), in Toronto, have discovered genetic risk factors for OCD that could help pave the way for earlier diagnosis and improved treatment for children and youth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE